CVS Group (LON:CVSG) Posts Earnings Results

CVS Group (LON:CVSG) released its earnings results on Thursday. The company reported GBX 85.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. CVS Group had a return on equity of 5.35% and a net margin of 2.31%.

Here are the key takeaways from CVS Group’s conference call:

• Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
• Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
• CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
• Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
• Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Trading Down 6.5%

LON:CVSG traded down GBX 85 on Thursday, hitting GBX 1,217. The stock had a trading volume of 505,795 shares, compared to its average volume of 880,590. The company has a fifty day moving average price of GBX 1,289.88 and a two-hundred day moving average price of GBX 1,230. The stock has a market cap of £827.19 million, a price-to-earnings ratio of 17.66, a PEG ratio of 1.77 and a beta of 1.07. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. CVS Group has a 1-year low of GBX 1,062 and a 1-year high of GBX 1,648.

Insider Buying and Selling

In related news, insider David Wilton bought 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was purchased at an average price of GBX 1,276 per share, for a total transaction of £19,140. Also, insider Joanne Shaw acquired 1,592 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was purchased at an average cost of GBX 1,287 per share, with a total value of £20,489.04. Over the last three months, insiders acquired 3,860 shares of company stock worth $4,956,696. Company insiders own 1.48% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Shore Capital Group restated a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a research note on Thursday. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a report on Thursday. Jefferies Financial Group upped their price target on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,700 price objective on shares of CVS Group in a research note on Monday, July 27th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, CVS Group presently has an average rating of “Moderate Buy” and an average price target of GBX 1,666.67.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.